Oppenheimer has downgraded Integra LifeSciences (NASDAQ:IART) to perform and withdrawn its price target over continued delays in the resumption of product distribution from the company's Boston ...

*Estimated payments are calculated by Cars.com and are for informational purposes only. We’ve estimated your taxes based on your provided ZIP code. These estimates do not include title ...

building a leadership position for Integra in the ENT segment and providing immediate scale and accretive growth via a dedicated sales channel. Unfavorable product and geographic mix and Boston ...

Integra LifeSciences explained that it had determined that the Boston Facility deviated from good manufacturing practices in testing for bacterial endotoxin and allowed the release of products ...

Integra's management team will reference a presentation ... of all products manufactured at the Company’s facility in Boston, Massachusetts and the transition of Boston-related manufacturing ...

It has been about a month since the last earnings report for Integra LifeSciences (IART). Shares have lost about 7.5% in that time frame, underperforming the S&P 500. Will the recent negative ...

Integra LifeSciences Holdings Corporation IART is successfully broadening its international footprint through certain key developments on the overseas front. The company also sees healthy demand ...

VANCOUVER, BC, March 28, 2025 /PRNewswire/ - Integra Resources Corp. ("Integra" or the "Company") (TSXV: ITR) (NYSE American: ITRG) is pleased to announce that Sean Deissner has been appointed to ...

INTEGRA Biosciences has played a pivotal role in advancing the field of serological pipetting over the last 40 years, and has just created a fascinating article covering the fast-paced history of ...